COMMONWEALTH EQUITY SERVICES, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$411
-20.5%
25,877
-5.5%
0.00%0.0%
Q2 2023$517
-24.9%
27,379
-84.7%
0.00%0.0%
Q1 2023$688
-17.9%
179,219
+6.0%
0.00%
-50.0%
Q4 2022$838
-99.9%
169,094
+1.4%
0.00%0.0%
Q3 2022$796,000
+5.6%
166,685
-0.5%
0.00%0.0%
Q2 2022$754,000
+427.3%
167,589
+457.6%
0.00%
Q1 2022$143,000
-36.2%
30,055
-0.5%
0.00%
-100.0%
Q4 2021$224,000
+30.2%
30,216
-0.4%
0.00%
Q3 2021$172,000
+11.7%
30,336
+29.1%
0.00%
Q2 2021$154,000
-56.9%
23,506
-46.7%
0.00%
-100.0%
Q1 2021$357,000
+120.4%
44,086
+74.5%
0.00%
Q4 2020$162,000
+76.1%
25,258
-1.8%
0.00%
Q3 2020$92,000
-14.0%
25,724
+9.7%
0.00%
Q2 2020$107,000
-31.4%
23,452
-49.0%
0.00%
-100.0%
Q1 2020$156,000
-18.3%
45,999
+22.4%
0.00%0.0%
Q4 2019$191,000
+41.5%
37,596
-33.0%
0.00%0.0%
Q3 2019$135,000
+350.0%
56,084
+304.3%
0.00%
Q2 2019$30,000
-68.8%
13,871
-61.2%
0.00%
Q1 2019$96,000
+39.1%
35,729
+146.9%
0.00%
Q4 2018$69,000
-51.7%
14,470
-4.3%
0.00%
-100.0%
Q3 2018$143,000
-2.7%
15,113
-0.1%
0.00%0.0%
Q2 2018$147,0000.0%15,135
+8.2%
0.00%0.0%
Q1 2018$147,000
+45.5%
13,986
-10.8%
0.00%0.0%
Q4 2017$101,00015,6780.00%
Other shareholders
IMMUNOGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 600,000$3,870,0002.25%
CM Management, LLC 375,000$2,419,0002.24%
Consonance Capital Management LP 3,515,944$22,678,0002.12%
RA Capital Management 18,417,458$118,793,0001.66%
Kercheville Advisors, LLC 244,421$1,564,0000.85%
Redmile Group, LLC 10,528,179$67,907,0000.82%
Birchview Capital, LP 190,000$1,226,0000.71%
QVT Financial LP 1,375,900$8,875,0000.49%
Fernwood Investment Management, LLC 149,340$963,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$671,0000.21%
View complete list of IMMUNOGEN INC shareholders